Client Result

Genetic Testing Lab Target Assessment

Project Overview

A large pharmaceutical company asked DeciBio to help it identify and evaluate clinical genetic testing labs for potential partnership or acquisition

DeciBio Approach

Secondary Research

  • Compiled a list of 400+ U.S. genetic testing laboratories from public sources (e.g., databases, press releases, etc.)
  • Developed and applied a prioritization framework based on both commercial and technical factors to narrow the list to 10 candidates of highest viability for partnership or acquisition
  • Conducted deep dives into the 4 most attractive potential targets, detailing financial, competitive, product, and strategic positioning of each potential target

Primary Research

  • Conducted 4 interviews with genomics laboratory and market KOLs to assist in company deep dives

‍

At a glance
400+
Laboratories Considered
4
Deep Dive Target Profiles
Outcomes

Based on DeciBio's analysis, the client proceeded with discussions and deeper diligence on the target labs, and engaged in a large-scale genomics collaboration with one of the targets.

Timeline

4 weeks

Geographic Scope

U.S.

Industry

Clinical Diagnostics

capabilities

Target Identification

Related Client Results
Clinical Diagnostics
MRD Monitoring Market Assessment and Strategy
A diagnostics player wanted to determine which indications and use cases to target and develop a product road map for its planned MRD offering
Biomarker and Diagnostic Strategy
Go-to-Market Strategy
Clinical Diagnostics
Early Cancer Detection Competitor Landscape Monitoring
A top diagnostics player wanted to monitor the commercial, clinical, research, and corporate activities in the public domain for three of the key players in the cancer early detection market.
Competitive Analysis
Clinical Diagnostics
IVDR Diagnostics Strategy
A top-10 diagnostics company wanted to gauge laboratory preparedness and reactions to the impending implementation of IVDR, and how that would impact portfolio strategy
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy
Clinical Diagnostics
Oncology Diagnostics Landscape Assessment and Model
DeciBio performed a global voice-of-customer (VOC) research campaign with oncologists and pathologists to understand the current adoption and expected trends for NGS kits in oncology diagnostics in the U.S., EU, and APAC.
Voice-Of-Customer Research
Biomarker and Diagnostic Strategy

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Precision Medicine. Precision Insights.
© DeciBio 2022. All rights reserved.
Privacy | Terms & Conditions